Avigenix Innovations Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 6 Year, 16 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.80 M
- Revenue Growth -33.24%
- Profit Growth 6.78%
- Ebitda 19.05%
- Net Worth -87.61%
- Total Assets -14.16%
About Avigenix Innovations
Avigenix Innovations Private Limited (AIPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 January 2019 (Six years 16 days old ). Its registered office is in 24 Parganas, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹2.80 M.
Anirban Chatterjee, Suvomoy Paul, and Rajesh Banik serve as directors at the Company.
Company Details
-
Location
24 Parganas, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24290WB2019PTC230047
-
Company No.
230047
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Jan 2019
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Avigenix Innovations?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anirban Chatterjee
|
Director | 25-Jan-2019 | Current |
|
Suvomoy Paul
|
Director | 25-Jan-2019 | Current |
|
Rajesh Banik
|
Director | 25-Jan-2019 | Current |
Financial Performance of Avigenix Innovations.
Avigenix Innovations Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 33.24% decrease. The company also saw a slight improvement in profitability, with a 6.78% increase in profit. The company's net worth observed a substantial decline by a decrease of 87.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Avigenix Innovations?
In 2021, Avigenix Innovations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Skinsync Epharmacy Private LimitedAnirban Chatterjee and Suvomoy Paul are mutual person
Charges (Loans)
₹2.80 M
₹0
Charges Breakdown by Lending Institutions
- Uco Bank : 0.28 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Jan 2024 | Uco Bank | ₹2.80 M | Open |
How Many Employees Work at Avigenix Innovations?
Avigenix Innovations has a workforce of 17 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Avigenix Innovations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avigenix Innovations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
